Copyright Reports & Markets. All rights reserved.

Global Alpha- Antitrypsin Deficiency Treatment Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Alpha- Antitrypsin Deficiency Treatment

      • 1.1 Definition of Alpha- Antitrypsin Deficiency Treatment
      • 1.2 Alpha- Antitrypsin Deficiency Treatment Segment by Type
        • 1.2.1 Global Alpha- Antitrypsin Deficiency Treatment Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 CT-2009
        • 1.2.3 POL-6014
        • 1.2.4 ARO-AAT
        • 1.2.5 ALNAAT-02
        • 1.2.6 Others
      • 1.3 Alpha- Antitrypsin Deficiency Treatment Segment by Applications
        • 1.3.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Clinic
        • 1.3.3 Hospital
        • 1.3.4 Others
      • 1.4 Global Alpha- Antitrypsin Deficiency Treatment Overall Market
        • 1.4.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue (2014-2025)
        • 1.4.2 Global Alpha- Antitrypsin Deficiency Treatment Production (2014-2025)
        • 1.4.3 North America Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.4 Europe Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.5 China Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.6 Japan Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.8 India Alpha- Antitrypsin Deficiency Treatment Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Alpha- Antitrypsin Deficiency Treatment
      • 2.3 Manufacturing Process Analysis of Alpha- Antitrypsin Deficiency Treatment
      • 2.4 Industry Chain Structure of Alpha- Antitrypsin Deficiency Treatment

      3 Development and Manufacturing Plants Analysis of Alpha- Antitrypsin Deficiency Treatment

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Alpha- Antitrypsin Deficiency Treatment Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Alpha- Antitrypsin Deficiency Treatment
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Alpha- Antitrypsin Deficiency Treatment Production and Capacity Analysis
      • 4.2 Alpha- Antitrypsin Deficiency Treatment Revenue Analysis
      • 4.3 Alpha- Antitrypsin Deficiency Treatment Price Analysis
      • 4.4 Market Concentration Degree

      5 Alpha- Antitrypsin Deficiency Treatment Regional Market Analysis

      • 5.1 Alpha- Antitrypsin Deficiency Treatment Production by Regions
        • 5.1.1 Global Alpha- Antitrypsin Deficiency Treatment Production by Regions
        • 5.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Regions
      • 5.2 Alpha- Antitrypsin Deficiency Treatment Consumption by Regions
      • 5.3 North America Alpha- Antitrypsin Deficiency Treatment Market Analysis
        • 5.3.1 North America Alpha- Antitrypsin Deficiency Treatment Production
        • 5.3.2 North America Alpha- Antitrypsin Deficiency Treatment Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Alpha- Antitrypsin Deficiency Treatment Import and Export
      • 5.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Analysis
        • 5.4.1 Europe Alpha- Antitrypsin Deficiency Treatment Production
        • 5.4.2 Europe Alpha- Antitrypsin Deficiency Treatment Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Alpha- Antitrypsin Deficiency Treatment Import and Export
      • 5.5 China Alpha- Antitrypsin Deficiency Treatment Market Analysis
        • 5.5.1 China Alpha- Antitrypsin Deficiency Treatment Production
        • 5.5.2 China Alpha- Antitrypsin Deficiency Treatment Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Alpha- Antitrypsin Deficiency Treatment Import and Export
      • 5.6 Japan Alpha- Antitrypsin Deficiency Treatment Market Analysis
        • 5.6.1 Japan Alpha- Antitrypsin Deficiency Treatment Production
        • 5.6.2 Japan Alpha- Antitrypsin Deficiency Treatment Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Alpha- Antitrypsin Deficiency Treatment Import and Export
      • 5.7 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Analysis
        • 5.7.1 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Production
        • 5.7.2 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Import and Export
      • 5.8 India Alpha- Antitrypsin Deficiency Treatment Market Analysis
        • 5.8.1 India Alpha- Antitrypsin Deficiency Treatment Production
        • 5.8.2 India Alpha- Antitrypsin Deficiency Treatment Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Alpha- Antitrypsin Deficiency Treatment Import and Export

      6 Alpha- Antitrypsin Deficiency Treatment Segment Market Analysis (by Type)

      • 6.1 Global Alpha- Antitrypsin Deficiency Treatment Production by Type
      • 6.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Type
      • 6.3 Alpha- Antitrypsin Deficiency Treatment Price by Type

      7 Alpha- Antitrypsin Deficiency Treatment Segment Market Analysis (by Application)

      • 7.1 Global Alpha- Antitrypsin Deficiency Treatment Consumption by Application
      • 7.2 Global Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Application (2014-2019)

      8 Alpha- Antitrypsin Deficiency Treatment Major Manufacturers Analysis

      • 8.1 Adverum Biotechnologies, Inc.
        • 8.1.1 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.1.2 Adverum Biotechnologies, Inc. Product Introduction, Application and Specification
        • 8.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Alnylam Pharmaceuticals, Inc.
        • 8.2.1 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.2.2 Alnylam Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Applied Genetic Technologies Corporation
        • 8.3.1 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.3.2 Applied Genetic Technologies Corporation Product Introduction, Application and Specification
        • 8.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Arrowhead Pharmaceuticals, Inc.
        • 8.4.1 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.4.2 Arrowhead Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Carolus Therapeutics, Inc.
        • 8.5.1 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.5.2 Carolus Therapeutics, Inc. Product Introduction, Application and Specification
        • 8.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Cevec Pharmaceuticals GmbH
        • 8.6.1 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.6.2 Cevec Pharmaceuticals GmbH Product Introduction, Application and Specification
        • 8.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Dicerna Pharmaceuticals, Inc.
        • 8.7.1 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.7.2 Dicerna Pharmaceuticals, Inc. Product Introduction, Application and Specification
        • 8.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Digna Biotech, S.L.
        • 8.8.1 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.8.2 Digna Biotech, S.L. Product Introduction, Application and Specification
        • 8.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Editas Medicine, Inc.
        • 8.9.1 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.9.2 Editas Medicine, Inc. Product Introduction, Application and Specification
        • 8.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Grifols, S.A.
        • 8.10.1 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production Sites and Area Served
        • 8.10.2 Grifols, S.A. Product Introduction, Application and Specification
        • 8.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Inhibrx
      • 8.12 Intellia Therapeutics, Inc.
      • 8.13 International Stem Cell Corporation
      • 8.14 Ionis Pharmaceuticals, Inc.
      • 8.15 Kamada Ltd.
      • 8.16 Polyphor Ltd.
      • 8.17 ProMetic Life Sciences Inc.
      • 8.18 rEVO Biologics, Inc.
      • 8.19 Sangamo BioSciences, Inc.

      9 Development Trend of Analysis of Alpha- Antitrypsin Deficiency Treatment Market

      • 9.1 Global Alpha- Antitrypsin Deficiency Treatment Market Trend Analysis
        • 9.1.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Alpha- Antitrypsin Deficiency Treatment Regional Market Trend
        • 9.2.1 North America Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
        • 9.2.2 Europe Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
        • 9.2.3 China Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
        • 9.2.4 Japan Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
        • 9.2.5 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
        • 9.2.6 India Alpha- Antitrypsin Deficiency Treatment Forecast 2019-2025
      • 9.3 Alpha- Antitrypsin Deficiency Treatment Market Trend (Product Type)
      • 9.4 Alpha- Antitrypsin Deficiency Treatment Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Alpha- Antitrypsin Deficiency Treatment Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Alpha- Antitrypsin Deficiency Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Alpha- Antitrypsin Deficiency Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alpha- Antitrypsin Deficiency Treatment market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Alpha- Antitrypsin Deficiency Treatment in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Alpha- Antitrypsin Deficiency Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Adverum Biotechnologies, Inc.
        Alnylam Pharmaceuticals, Inc.
        Applied Genetic Technologies Corporation
        Arrowhead Pharmaceuticals, Inc.
        Carolus Therapeutics, Inc.
        Cevec Pharmaceuticals GmbH
        Dicerna Pharmaceuticals, Inc.
        Digna Biotech, S.L.
        Editas Medicine, Inc.
        Grifols, S.A.
        Inhibrx
        Intellia Therapeutics, Inc.
        International Stem Cell Corporation
        Ionis Pharmaceuticals, Inc.
        Kamada Ltd.
        Polyphor Ltd.
        ProMetic Life Sciences Inc.
        rEVO Biologics, Inc.
        Sangamo BioSciences, Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        CT-2009
        POL-6014
        ARO-AAT
        ALNAAT-02
        Others

        Segment by Application
        Clinic
        Hospital
        Others

        Buy now